Market Outlook 2034: Strategic Developments in Angiotensin Receptor Antagonist Therapies
The Angiotensin Receptor Antagonists Market is expanding as healthcare providers increasingly use angiotensin receptor blockers (ARBs) for the management of hypertension and other cardiovascular and renal conditions. These medicines act by blocking the effects of angiotensin II at its receptors, helping reduce blood vessel constriction and support blood pressure control. Market...
0 Comments 0 Shares 8 Views 0 Reviews